The Indian risk capital industry had investments of $9.3bn in 2011. But it is feared the taxation proposals in Budget 2012 will create roadblocks to future growth. This piece, first published by The Economic Times of India, explains why the right policy framework can boost risk capital inflow to $200bn by 2020.

Now they have developed a new approach to their open innovation efforts called X3 and I really like how they focus on the need for facilitators.

Burrill & Company identified more than $2.6bn in expected funding through nine healthcare initiatives announced since the end of February to end-March.

This is the first in a bimonthly series of articles about the personal alternative investments markets available to the professional corporate venturer. This new section in Global Corporate Venturing magazine looks beyond our readers' day jobs at how they manage their time and wealth using the same skills of insight, trend analysis and managing risk they bring to their professional careers.

Strategically-minded corporate partners with patience, experience and industry value-chain contacts, may be able to exploit a genuinely exciting opportunity.

Global Agenda Council on Emerging Technologies at the World Economic Forum list its top 10 - image from last year's tech pioneer.

Nanotechnology does come with considerations, notably environmental, health and safety issues. But correctly managed such risks do not stand in the way of nanotech's economic and industrial future.

The current generation of corporate venturing funds has learnt some lessons from the failures in the past decade.

Far from US corporations having an excess of cash, there appears to be a cash deficit.

In our series of interviews with leading innovation and venture developers, Andrew Gaule, left, founder of the Corporate Venturing Network, talks to David Phillips, partner at SR One, GlaxoSmithKline's corporate venturing unit.